Logo Skip to main content
  • About
  • Team
  • Technology
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact

Press Releases

2023

April 24, 2023
Valitor Presents Preclinical Data on its Long-acting Anti-VEGF Biologic in Development for Durable Treatment of Wet AMD at the Association for Research in Vision and Ophthalmology Annual Meeting

April 10, 2023
Valitor to Present on the Potential for its Multivalent Polymer Technology to Expand the Therapeutic Index of Oncology Agents at the 2023 American Association for Cancer Research Annual Meeting

March 23, 2023
Valitor to Present at the Association for Research in Vision and Ophthalmology Annual Meeting

2022

December 01, 2022
Valitor Announces Presentation on Novel Anti-VEGF Antibody Conjugate and Multivalent Polymer Technology Platform at Upcoming Ophthalmology Innovation Source (OIS) Summit - Preclinical data support twice-yearly dosing in wet AMD -

October 05, 2022
Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer

  • Home
  • About
  • Team
  • Technology
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • Privacy Policy
  • Terms of Use
  • LinkedIn
Valitor, Inc. Logo

Valitor, Inc.
Bakar Labs
2630 Bancroft Ave
Berkeley, CA 94704
Phone: (510) 545-6062
Fax: (510) 647-8429

Contact

Business Development
bd@valitorbio.com

General Inquiries
info@valitorbio.com

Careers
careers@valitorbio.com

  • LinkedIn
  • Privacy Policy
  • Terms of Use
© 2023 Valitor, Inc. All rights reserved.
Website Design: Hane Chow, Inc.